News and Announcements
Leaf Resources signs MOU with Norske Skog
- Published August 13, 2015 2:54PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
11th August 2015, ASX Announcement
The Directors of Leaf Resources advise that a Memorandum of Understanding has been signed with Norske Skog Industries Australia Ltd to work together to evaluate yields from the Radiata pine using Leaf Resources’ GlycellTM process.
The work will investigate the suitability for conversion of softwood, Radiata Pine, to cellulosic sugars, and the subsequent conversion of those sugars to biomass derived chemicals.
Leaf Resources and Norske Skog will work together to demonstrate the performance of the GlycellTM process on Radiata Pine and the possible future uses of this technology.
Leaf Resources has data from preliminary work with softwood and will further develop this, in the work stages of testing of the GlycellTM process using Radiata Pine at Andritz’s testing facility in Springfield Ohio. (Andritz’s is a leading global supplier of plant, equipment and services for pulp and paper making and other industries).
To read the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
